An underground market for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, based on new investigations.
Experimental Drug Acquiring Popularity Online
Retatrutide, which remains in clinical trials, is being advertised by social media influencers for its alleged fat-burning properties. Followers are encouraged to message these accounts privately for supplier links, while also obtaining promotional offers.
Active Trade on Social Networks
Separately, a flourishing trade exists on Telegram, where groups with numerous of participants share comparison images, injection guides and claims of next-day British shipping. Sellers market the drug there before directing buyers to WhatsApp for transactions.
Learning About Retatrutide
Retatrutide is an investigational injectable developed by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could assist individuals lose up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted digitally as the next Ozempic.
Healthcare Professionals Voice Worries
However, physicians and pharmacists have warned that the distribution of what remains an unlicensed drug in the UK is a cause for concern and could lead to individuals administering substances of unknown origin.
Some experts stated the popularity for retatrutide could be connected to the rising cost of licensed weight loss treatments such as Mounjaro.
Legal Status and Implementation
Marketing retatrutide on TikTok or Telegram is prohibited in the United Kingdom, as it is an unapproved drug that cannot be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.
Several influencers attempt to sidestep the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and distribution can still violate pharmaceutical, marketing, and customer regulations, risking penalties, prosecution or imprisonment.
Service Reaction and Material Elimination
According to the social media company, the service has taken down violative content and prohibited related keywords and search suggestions. The organization said it was dedicated to maintaining the service secure and investing in strengthening compliance measures.
Digital Marketplace Operations
Research also found communities with up to nine thousand participants selling retatrutide using the platform's built-in discovery tool, which functions like a public directory. Typing “retatrutide” immediately displays groups with thousands of members, filled with images of slimming results, positive reviews and detailed guides for mixing or injecting at home.
After minutes of joining one group, a vendor posted WhatsApp details, where most purchases take place. The vendor sent an instruction manual and promised shipping within 48 hours. When questioned whether the substance was genuine, one vendor responded: “You can’t be sure.” Another shared a photo of a alleged testing documentation. Not one asked about body mass, medical conditions or previous experience.
Item Information and Pricing
Within these groups, messages show dark colored parcels with Royal Mail stickers, claiming to contain new batches. One message read: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, mixed at home with purified liquid, or pre-filled pens usually priced at 160 pounds for 20mg. When questioned how long a pen should last, vendors give conflicting answers varying between a several days to “depends on your body”.
Platform Oversight and Safety Actions
A spokesperson for Telegram stated it regularly monitored harmful content on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“Individuals are injecting materials they can’t verify. Although the science behind retatrutide is sound, these digital versions may not contain what they advertise,” stated Jason Murphy, the head of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of an online medical service connected the increase in demand to recent cost increases for authorized weight-loss drugs such as Mounjaro. “With prices increasing, individuals are using social media. But fake treatments are extremely dangerous. You cannot know what’s inside or whether the conditions they were produced in was sterile,” she said.
Her team has previously encountered individuals injured by self-injection from unconfirmed suppliers. “We understand the frustration, but buying from messaging apps or WhatsApp is taking chances with your health,” said Wyllie. “These substances could be contaminated or incorrectly dosed.”
Producer Statement
A spokesperson from the pharmaceutical company stated retatrutide was in phase 3 research studies and had not been reviewed or approved by any regulatory agency anywhere in the world. “Consequently at this point no one can sell [it] for personal consumption,” they said, adding that any product “falsely representing itself as a Lilly experimental product not yet authorized … may subject patients to potentially serious health risks”.
